Pentixapharm’s CXCR4 Core Compound Subject of 17 Abstract Presentations at the Hamburg European Association of Nuclear Medicine (EANM) 19.10.2024 / 12:28 CET/CEST The issuer is solely responsible for ...
Some results have been hidden because they may be inaccessible to you